BBS-Bioactive Bone Substitutes Oyj

BONEH

FI4000260583

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Helsinki Other stock markets 12:00:00 2024-06-27 EDT			5-day change	1st Jan Change
0.352 ^EUR	+0.86%		+5.07%	-28.02%

06-13	BBS-Bioactive Bone Substitutes Oyj Approves Election of Gregor Siebert as New Member to the Board of Directors	CI
06-04	BBS-Bioactive Bone Substitutes Plc Announces Approval of Complementary Patent Application for the ARTEBONE® Product	CI

BBS-Bioactive Bone Substitutes Oyj Approves Election of Gregor Siebert as New Member to the Board of Directors

June 13, 2024 at 11:00 am

BBS-Bioactive Bone Substitutes Oyj announced at the AGM held on June 13, 2024, approved Gregor Siebert was elected as a new Member to the Board of Directors.

Latest news about BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Oyj Approves Election of Gregor Siebert as New Member to the Board of Directors	06-13	CI
BBS-Bioactive Bone Substitutes Plc Announces Approval of Complementary Patent Application for the ARTEBONE® Product	06-04	CI
BBS-Bioactive Bone Substitutes Plc Announces Ahti Paananen Not Available for Re-Election to the Board of Directors	05-23	CI
Bbs-Bioactive Bone Substitutes Oyj Announces the Cessation of Jari Kortesluoma as Member of the Management Team	03-06	CI
Bbs-Bioactive Bone Substitutes Oyj Announces the Cessation of Jari Kortesluoma as CFO	03-06	CI
Oy Jamerco Ltd. Terminates Its Service Contract with BBS-Bioactive Bone Substitutes Oyj	03-06	CI
BBS-Bioactive Bone Substitutes Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	02-26	CI
BBS-Bioactive Bone Substitutes Obtains Financing for Working Capital	02-21	MT
Bbs-Bioactive Bone Substitutes plc Appoints Kimmo Tyni as Product Director, effective January 15, 2024	01-02	CI
BBS-Bioactive Bone Substitutes Plc Announces Director Changes	12-27	CI
BBS-Bioactive Bone Substitutes Closes EUR2 Million Rights Issue	12-19	MT
BBS-Bioactive Bone Substitutes Closes EUR2 Million Rights Issue	12-19	MT
BBS-Bioactive Bone Substitutes Secures Subscription Pledges from Two Investors for Rights Offering	11-27	MT
BBS-Bioactive Updates Schedules of CE Marking Process for Bone Void Filler Product	11-03	MT
BBS-Bioactive Bone Substitutes Plc Announces CEO Changes	23-10-03	CI
Finland's BBS-Bioactive to Convert Notes	23-09-15	MT
BBS-Bioactive Bone Substitutes Issues Shares without Consideration; Stock Drops 10%	23-09-04	MT
BBS-Bioactive Bone Substitutes Oyj Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
BBS-Bioactive Bone Substitutes Oyj Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-24	CI
BBS-Bioactive Bone Substitutes Oyj Provides Financial Guidance for 2023	23-02-24	CI
BBS-Bioactive Bone Substitutes Gets Approval to Delist from Swedish Bourse	23-02-17	MT
BBS-Bioactive Bone Substitutes To Withdraw Nasdaq First North Growth Market Sweden Listing	22-11-04	MT
Bbs-Bioactive Bone Substitutes plc Announces Appointment of Jari Kortesluoma as Member of the Management Team	22-10-07	CI
Bbs-Bioactive Bone Substitutes Oyj Announces Appointment of Jari Kortesluoma as CFO	22-10-07	CI
BBS-Bioactive Bone Substitutes CFO to Quit in September	22-08-31	MT

Chart BBS-Bioactive Bone Substitutes Oyj

Duration

Period

Chart BBS-Bioactive Bone Substitutes Oyj

More charts

BBS-Bioactive Bone Substitutes Oyj (BBS) is a Finland-based company engaged in the medical equipment industry. The Company operates as a biotechnology company that develops and distributes medical device implants used in orthopedic surgery. Its products include ARTEBONE, an orthopedic bone substitute material made from reindeer bone protein matrix made using a propriety patented manufacturing process that can be used in various application areas, such as bone regeneration, healing of fractures, non-unions, bone defect, dental implantation, orthopedics, maxillofacial/dental surgery and osteoporotic fractures.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-29 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

0.352 EUR

Average target price

0.4 EUR

Spread / Average Target

+13.64%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
BBS-BIOACTIVE BONE SUBSTITUTES OYJ	-28.02%	7.19M
STRYKER CORPORATION	+13.72%	130B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-17.54%	7.37B
GLAUKOS CORPORATION	+47.67%	5.87B
INSPIRE MEDICAL SYSTEMS, INC.	-33.48%	4.1B
AXONICS, INC.	+8.31%	3.44B
ENOVIS CORPORATION	-19.83%	2.47B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-16.33%	1.94B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-24.61%	1.72B
DOUBLE MEDICAL TECHNOLOGY INC.	-36.56%	1.51B

Medical Devices & Implants